CABERGOLINE
Clinical Indication
Parkinson's disease
Comments
For new patients, existing patients to remain on therapy.
Date of classification
October 2021
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.